ME Therapeutics Holdings Statistics
Total Valuation
CSE:METX has a market cap or net worth of CAD 196.42 million. The enterprise value is 195.21 million.
Market Cap | 196.42M |
Enterprise Value | 195.21M |
Important Dates
The last earnings date was Friday, March 21, 2025.
Earnings Date | Mar 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:METX has 26.19 million shares outstanding. The number of shares has increased by 27.71% in one year.
Current Share Class | n/a |
Shares Outstanding | 26.19M |
Shares Change (YoY) | +27.71% |
Shares Change (QoQ) | -0.02% |
Owned by Insiders (%) | 64.02% |
Owned by Institutions (%) | n/a |
Float | 9.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 142.37 |
P/TBV Ratio | 148.02 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -155.81 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -357.08 |
Financial Position
The company has a current ratio of 8.18, with a Debt / Equity ratio of 0.08.
Current Ratio | 8.18 |
Quick Ratio | 7.70 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | -0.20 |
Interest Coverage | -472.52 |
Financial Efficiency
Return on equity (ROE) is -145.75% and return on invested capital (ROIC) is -87.97%.
Return on Equity (ROE) | -145.75% |
Return on Assets (ROA) | -81.00% |
Return on Invested Capital (ROIC) | -87.97% |
Return on Capital Employed (ROCE) | -95.06% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +207.92% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +207.92% |
50-Day Moving Average | 8.38 |
200-Day Moving Average | 5.10 |
Relative Strength Index (RSI) | 35.69 |
Average Volume (20 Days) | 231 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.32M |
Pretax Income | -1.25M |
Net Income | -1.25M |
EBITDA | -1.31M |
EBIT | -1.32M |
Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 1.33 million in cash and 110,739 in debt, giving a net cash position of 1.22 million or 0.05 per share.
Cash & Cash Equivalents | 1.33M |
Total Debt | 110,739 |
Net Cash | 1.22M |
Net Cash Per Share | 0.05 |
Equity (Book Value) | 1.33M |
Book Value Per Share | 0.05 |
Working Capital | 1.26M |
Cash Flow
In the last 12 months, operating cash flow was -537,834 and capital expenditures -8,834, giving a free cash flow of -546,668.
Operating Cash Flow | -537,834 |
Capital Expenditures | -8,834 |
Free Cash Flow | -546,668 |
FCF Per Share | -0.02 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:METX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.71% |
Shareholder Yield | -27.71% |
Earnings Yield | -0.64% |
FCF Yield | -0.28% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |